Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 4,0B
Gross Profit 3,0B 74,92 %
Operating Income -120,4M -3,05 %
Net Income -16,6M -0,42 %
EPS (Diluted) -0,08 US$

Balance Sheet Metrics

Total Assets 8,7B
Total Liabilities 5,4B
Shareholders Equity 3,3B
Debt to Equity 1,62

Cash Flow Metrics

Operating Cash Flow 1,3B
Free Cash Flow 1,1B

Revenue & Profitability Trend

Income Statement

Metric 2025 2024 2023 2022 2021
Revenue 4,0B 3,1B 2,2B 1,5B 874,4M
Cost of Goods Sold 991,5M 755,7M 601,2M 383,2M 229,5M
Gross Profit 3,0B 2,3B 1,6B 1,1B 644,9M
Operating Expenses 3,1B 2,3B 1,8B 1,2B 737,4M
Operating Income -120,4M -2,0M -190,1M -142,5M -92,5M
Pre-tax Income 54,5M 122,8M -159,9M -160,0M -87,9M
Income Tax 71,1M 32,2M 22,4M 72,4M 4,8M
Net Income -16,6M 90,6M -182,3M -232,4M -92,6M
EPS (Diluted) -0,08 US$ 0,37 US$ -0,79 US$ -1,03 US$ -0,43 US$

Income Statement Trend

Balance Sheet

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 6,1B 4,8B 3,6B 2,6B 2,3B
Non-Current Assets 2,6B 1,9B 1,4B 1,0B 440,3M
Total Assets 8,7B 6,6B 5,0B 3,6B 2,7B
Liabilities
Current Liabilities 3,5B 2,7B 2,1B 1,4B 863,6M
Non-Current Liabilities 1,9B 1,6B 1,4B 1,2B 997,1M
Total Liabilities 5,4B 4,3B 3,5B 2,6B 1,9B
Equity
Total Shareholders Equity 3,3B 2,3B 1,5B 1,0B 871,9M

Balance Sheet Composition

Cash Flow Statement

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income -16,6M 90,6M -182,3M -232,4M -92,6M
Operating Cash Flow 1,3B 1,2B 865,5M 538,0M 288,8M
Investing Activities
Capital Expenditures -254,9M -176,5M -235,0M -112,1M -52,8M
Investing Cash Flow -477,6M -280,1M -525,2M -543,0M 506,5M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 3,6M 8,1M 9,4M 6,4M 737,0M
Free Cash Flow 1,1B 929,1M 674,6M 441,1M 292,7M

Cash Flow Trend

Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 716,55
Forward P/E 112,56
Price to Book 34,69
Price to Sales 28,96
PEG Ratio 112,56

Profitability Ratios

Profit Margin -4,17 %
Operating Margin -10,70 %
Return on Equity -5,74 %
Return on Assets -1,47 %

Financial Health

Current Ratio 1,85
Debt to Equity 22,50
Beta 1,16

Per Share Data

EPS (TTM) -0,72 US$
Book Value per Share 13,86 US$
Revenue per Share 16,80 US$

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
crwd 119,8B 716,55 34,69 -5,74 % -4,17 % 22,50
Microsoft 3,3T 34,84 10,40 33,61 % 35,79 % 32,63
Oracle 603,5B 49,48 28,79 82,38 % 21,68 % 496,47
Palo Alto Networks 130,9B 112,15 18,08 21,16 % 13,95 % 11,15
Fortinet 77,2B 41,49 39,51 205,91 % 30,60 % 54,84
Synopsys 74,3B 55,23 7,49 15,55 % 34,77 % 108,34

Financial data is updated regularly. All figures are in the company's reporting currency.